Your browser doesn't support javascript.
loading
A 5-year follow-up to evaluate the efficacy and safety of ofatumumab added to fludarabine and cyclophosphamide in patients with relapsed chronic lymphocytic leukemia: final analysis of the COMPLEMENT 2 trial.
Grosicki, Sebastian; Lech-Maranda, Ewa; Govind Babu, Kanakasetty; Rybka, Justyna; Litvinskaya, Elena; Loscertales, Javier; Kriachok, Iryna; Kloczko, Janusz; Rekhtman, Grygoriy; Homenda, Wojciech; Blonski, Jerzy; Stefanelli, Tommaso; Vincent, Ghislaine; Banerjee, Hiya; Robak, Tadeusz.
Afiliación
  • Grosicki S; Department of Hematology and Cancer Prevention in Chorzow, Faculty of Health Sciences Bytom, Silesian Medical University in Katowice, Katowice, Poland.
  • Lech-Maranda E; Department of Hematology, Institute of Haematology and Transfusion Medicine, Warsaw, Poland.
  • Govind Babu K; Department of Medical Oncology, Kidwai Memorial Institute of Oncology, HCG Hospitals Bangalore, Bengaluru, India.
  • Rybka J; Department of Medical Oncology, Wroclaw Medical University, Wroclaw, Poland.
  • Litvinskaya E; Russian Research Institute of Hematology and Transfusiology, St. Petersburg, Russian Federation.
  • Loscertales J; Hospital Universitario de La Princesa, IIS-IP, Madrid, Spain.
  • Kriachok I; Oncohematology Department, National Cancer Institute, Kiev, Ukraine.
  • Kloczko J; Department of Hematology, Medical University of Bialystok, Poland.
  • Rekhtman G; Khmelnytskyi Regional Hospital, Khmelnytskyi, Ukraine.
  • Homenda W; Department of Hematology and Pomeranian Academy in Slupsk, Department of Health Sciences, The Janusz Korczak State Hospital in Slupsk, Medical University of Bialystok, Bialystok, Poland.
  • Blonski J; Department of Hematology, Medical University of Lodz and Copernicus Memorial Hospital, Lodz, Poland.
  • Stefanelli T; Novartis Pharma AG, Basel, Switzerland.
  • Vincent G; Novartis Pharma S.A.S., Paris, France.
  • Banerjee H; Novartis Oncology, East Hanover, NJ, USA.
  • Robak T; Department of Hematology, Medical University of Lodz and Copernicus Memorial Hospital, Lodz, Poland.
Leuk Lymphoma ; 61(7): 1748-1751, 2020 07.
Article en En | MEDLINE | ID: mdl-32107948
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Leucemia Linfocítica Crónica de Células B Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Leuk Lymphoma Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Polonia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Leucemia Linfocítica Crónica de Células B Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Leuk Lymphoma Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Polonia